The Theranos Saga Has Ended: Elizabeth Holmes Sentenced To 11 Years In Prison
A pregnant Elizabeth Holmes appeared in court on Friday to hear the sentence for the four charges of fraud she
Read more
Biotech
Judge Denies Elizabeth Holmes’ Request For New Trial, Sentencing To Proceed On November 18
Elizabeth Holmes, the disgraced founder of Theranos, will be sentenced on Friday, November 18 following an attempt to delay sentencing
Read more
Activist Investor Calls For MindMed CEO’s Termination Due To Alleged Fraudulent Acts
FCM MM Holdings, one of Mind Medicine’s (NEO: MMED) shareholders with a 6.1% stake, has formally filed a complaint with
Read more
Elon Musk’s Neuralink ‘Show & Tell’ Event Moved to November 30
Billionaire Elon Musk announced on Sunday – on Twitter, of course — that Neuralink’s ‘show and tell’ event will be
Read more
Mindmed: Canaccord Calls Financing “Puzzling And Unusual”
This past week Mind Medicine Inc. (NEO: MMED) announced that they would be doing a public offering of 7,058,823 units
Read more
Biogen Trades At 12-Month High Following Alzheimer’s Drug Success, US$900-Million Settlement On Kickback Lawsuit
Fresh off a US$900 million settlement agreement, Biogen, Inc (Nasdaq: BIIB) announced positive topline results from the phase 3 study
Read more
MindMed Starts Dosing Patients In Phase 1 Clinical Study On MDMA-Like Substances
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Tuesday that the first patient has been dosed
Read more
Cognetivity Sees Its Cognitive Tool Used In Clinical Study For OCD
While it may have been initially developed for the early detection of Alzheimer’s disease or other cognitive impairments in patients,
Read more
MindMed Sees Positive Results For Its LSD Treatment For Anxiety Disorders Published In Peer-Reviewed Journal
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday that the previously released positive topline data
Read more
Radiation Oncology Firm Shuttle Pharmaceuticals Prices US$10 Million IPO
Pharmaceutical company focused on radiation therapy treatment Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) started trading on the Nasdaq Capital Market
Read more